Eli Lilly reports positive Phase 3 results for oral obesity drug Orforglipron
At one year, the drug met its primary and all key secondary endpoints, delivering significantly better weight maintenance than placebo
At one year, the drug met its primary and all key secondary endpoints, delivering significantly better weight maintenance than placebo
The center will deliver Certified Pre-Owned instruments restored to factory-grade standards and backed by Agilent Standard Warranty
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
The update promises to revolutionize laboratory workflows by optimizing resources
The NP resin portfolio, indicated by its UL746G-certified prefix, equips manufacturers across industries to meet increasingly stringent regulatory and performance standards
The expansion includes a larger technical and service team and increased local procurement
Dr Kinha is a seasoned healthcare and diagnostics leader with over 17 years of experience across leading organisations in the diagnostics sector, with deep expertise in laboratory operations and quality systems
The move strengthens GBL’s clinical-stage presence in the United States
The combination also outperformed chemotherapy on another important secondary endpoint
Patients with BRCA mutations often face aggressive disease and poor prognosis
Subscribe To Our Newsletter & Stay Updated